Production (Stage)
OS Therapies Incorporated
OSTX
$1.67
$0.042.45%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.69M | 2.10M | 1.23M | 383.20K | 268.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.00M | 2.97M | 2.44M | 779.80K | 630.20K |
| Operating Income | -5.00M | -2.97M | -2.44M | -779.80K | -630.20K |
| Income Before Tax | -3.88M | -2.99M | -2.88M | -1.56M | -1.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.88M | -2.99M | -2.88M | -1.56M | -1.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.88M | -2.99M | -2.88M | -1.56M | -1.46M |
| EBIT | -5.00M | -2.97M | -2.44M | -779.80K | -630.20K |
| EBITDA | -5.00M | -2.97M | -2.44M | -779.10K | -629.50K |
| EPS Basic | -0.18 | -0.23 | -0.18 | -0.26 | -0.25 |
| Normalized Basic EPS | -0.11 | -0.09 | -0.11 | -0.16 | -0.15 |
| EPS Diluted | -0.18 | -0.23 | -0.18 | -0.26 | -0.25 |
| Normalized Diluted EPS | -0.11 | -0.09 | -0.11 | -0.16 | -0.15 |
| Average Basic Shares Outstanding | 21.25M | 21.76M | 15.90M | 5.99M | 5.99M |
| Average Diluted Shares Outstanding | 21.25M | 21.76M | 15.90M | 5.99M | 5.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |